Specifically in inflammatory skin diseases the role of moDCs has been proven in psoriasis, where they produce interleukin (IL)-1β and tumor necrosis factor (TNF) to amplify the inflammatory milieu, but are not solely responsible for it (26, 27). This evidence concerns the gene TNF and inflammatory skin disease.